# A Renal Impairment Study for PF-04965842

> **NCT03660241** · PHASE1 · COMPLETED · sponsor: **Pfizer** · enrollment: 23 (actual)

## Conditions studied

- Renal Impairment

## Interventions

- **DRUG:** PF-04965842

## Key facts

- **NCT ID:** NCT03660241
- **Lead sponsor:** Pfizer
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-10-05
- **Primary completion:** 2019-11-05
- **Final completion:** 2019-11-05
- **Target enrollment:** 23 (ACTUAL)
- **Last updated:** 2022-03-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03660241

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03660241, "A Renal Impairment Study for PF-04965842". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT03660241. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*